Investor · BURLINGAME, CA
Steven Tablak
Open Steven in the network graph →Capital
$134.5M
across filings
Active
Oct 2018
to Mar 2021
Most-connected co-filers (53)
David Persing · BURLINGAME, CA10 sharedPrime Management Company I, Llc · Cambridge, MA6 sharedMatthew C. Elston · St Peter Port, Y76 sharedMark D. Rodliffe · St Peter Port, Y76 sharedJohanna Wolfson · CAMBRIDGE, MA5 sharedMatthew Nordan · CAMBRIDGE, MA5 sharedPrime Management Company I, Llc · Cambridge, MA5 sharedMichael Rubin · BURLINGAME, CA4 sharedJingjing Zhang · Markham, IL2 sharedAusten Helfrich · Salt Lake City, UT2 sharedAcies Management LLC · Markham, IL2 sharedThejas Nalval · Hoboken, NJ2 sharedDavid Levine · Martinsburg, WV2 sharedMichael Sadhra · VANCOUVER, British Columbia, Canada2 sharedArnold Kozys · Markham, IL2 sharedJason M. Stein · Brooklyn, NY2 sharedSimon S. Zhang · Irvine, CA2 sharedSC Management LLC Management SC Management SC SC Management LLC · New York, NY2 sharedSC Management LLC Management SC Management SC Management LLC · New York, NY2 sharedJim Mccabe · Fort Lauderdale, FL2 sharedDana Stalder · San Francisco, CA2 sharedTimothy Sweeney · BURLINGAME, CA2 sharedKenneth Bahk · BURLINGAME, CA2 sharedJacob B. Frieberg · Rochester, NY2 shared Recent filings (12)
Inflammatix, Inc.Mar 2021 · 16 co-filers$102.4MAlgernon Pharmaceuticals Inc.May 2020 · 11 co-filers$128KInflammatix, Inc.Feb 2020 · 16 co-filers$32.1MPRIME Impact Equity Fund I, LLCSep 2019 · 4 co-filersPRIME Impact Equity Fund I, LLCJun 2019 · 7 co-filersPRIME Impact Loan Fund I, LLCApr 2019 · 7 co-filersPRIME Impact Equity Fund I, LLCApr 2019 · 7 co-filersBreathtec BioMedical, Inc.Oct 2018 · 11 co-filers$68KPRIME Impact Loan Fund I, LLCOct 2018 · 7 co-filersPRIME Impact Equity Fund I, LLCOct 2018 · 7 co-filersGeneWeave Biosciences, Inc.Jan 2015 · 20 co-filers$12.4MGeneWeave Biosciences, Inc.Mar 2012 · 5 co-filers$12.0M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Steven in the interactive graph →